On the one hand, high expression of PLIN2 was associated with poor MFS, DFS, and OS rates in cutaneous melanomas and related to poor prognosis in pancreatic ductal adenocarcinoma, breast cancer, and lung adenocarcinomas (12, 27, 33, 34). The gene discussed is PLIN2; the disease is breast cancer.